A Comparative Study of the Effect on Anxiety of Chlorpromazine,1 Reserpine,2 Phenobarbital, and a Placebo

Neuroleptics: Effects on Neuropsychological Function in Chronic Schizophrenic Patients

“…A major difficulty in identifying appropriate studies for review was ambiguity in the identification of the subject population. Studies in which subjects were identified only as “mental patients” (Allport et al 1963), “all psychiatric admissions” (Rosner et al 1955; Petrie and LeBeau 1956), “mixed psychiatric categories” (Shatin et al 1956; Winter and Frederickson 1956; Howard et al 1975), “chronic patients” (Mason-Browne and Borthwick 1957), or newly admitted patients suffering from an acute psychotic episode (Hamill and Fontana 1975; Wahba et al 1981) were not included in this review.…”

The Specificity of Reserpine in the Treatment of Schizophrenia in Identical Twins: A Controlled Experiment

“…Lemere (1955) reports that in his opinion there is no advantage in using one rather than the other and that the same patient may not tolerate the one and yet respond to the other drug. Rosner, Levine, Hess, and Kaye (1955) also found no significant differences in groups of patients treated with the two drugs. He noted, however, that the weight gain was greater with reserpine.…”

Chlorpromazine, Reserpine and Meprobamate: Psychological Effects.

“…Another comparison is by Rosner and co-workers (64). In comparing four groups receiving chlorpromazine, reserpine, phenobarbital, and a placebo, there were no differences between active drugs.…”